News 2020-03-10
The deputy mayor of Chongqing Visited Porton Changshou Site.
In the afternoon of Sep. 7th, 2015, the deputy mayor of Chongqing, Wu Gang, together with the district committee secretary, Zhou Yong, the district head, Zhao Shiqing, the deputy district head and director of Changshou development zone management committee, Ba Chuanjiang, the deputy director, Ren Ranhong & Song Ping and the leaders of Municipal science and technology commission visited Porton Changshou Site. The president of company, Andrew Xu, together with vice president David Lan and Victor Cao received the leaders.
Andrew introduced to the leaders in details on Porton’s CMO strategic positioning, the business development situation of last three years, the development strategy and target in the future. The deputy mayor affirmed Porton’s performance in the past years. Other leads also showed that they will continuously provide all-round support on Porton’s development and expect to drive the mutual development of pharmaceutical industry in Changshou development zone and Chongqing by Porton’s progress.Others
More
News 2026-08-05
Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization
Porton Advanced Solutions Ltd. has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Administration (NMPA). This milestone qualifies Porton Advanced to undertake commercial contract manufacturing for Cell and Gene Therapy (CGT) products, extending its CDMO services from process development and clinical production through to the commercialization stage.
News 2026-07-08
Porton Advanced's UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
